Quick Answer
TG THERAPEUTICS, INC. reported Long-Term Debt of $245.65 million for fiscal year 2025.
TG THERAPEUTICS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $245.65M | +0.5% |
| 2024 | $244.43M | +144.1% |
| 2023 | $100.12M | +40.7% |
| 2022 | $71.14M | +6.5% |
| 2021 | $66.79M | +765.6% |
| 2020 | $7.72M | -73.4% |
| 2019 | $28.97M | — |
| 2018 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $245.34M | +0.5% | +0.1% |
| June 30, 2025 | $245.04M | +139.0% | +0.1% |
| March 31, 2025 | $244.73M | +141.5% | +0.1% |
| December 31, 2024 | $244.43M | +144.1% | +0.1% |
| September 30, 2024 | $244.16M | +146.9% | +138.1% |
| June 30, 2024 | $102.54M | +5.0% | +1.2% |
| March 31, 2024 | $101.33M | +5.0% | +1.2% |
| December 31, 2023 | $100.12M | +40.7% | +1.2% |
- TG THERAPEUTICS, INC. showed an increase of +0.5% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from TG THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: